Needham Maintains Buy on Insight Molecular, Raises Price Target to $9
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
Needham analyst Mike Matson maintains Insight Molecular (NASDAQ:IMDX) with a Buy and raises the price target from $4.25 to $9.
Needham analyst Mike Matson maintains Insight Molecular (NASDAQ:IMDX) with a Buy and raises the price target from $4.25 to $9.